MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico

Miami, FL, May 02, 2025 –(PR.com)– MindScape Retreat, a pioneer in clinical psychedelic therapy programs, has released the results of a transformative case series evaluating the safety and efficacy of a 14-day ibogaine treatment program for Parkinson’s disease. The findings suggest that ibogaine, a naturally occurring psychoactive alkaloid, may offer disease-modifying benefits in PD through its unique neuroregenerative properties.

The study tracked 30 patients with idiopathic Parkinson’s disease (PD), ...

Continue Reading →
Gavriel Dardashti Details Ibogaine Protocol Enhancements,

Gavriel Dardashti Details Ibogaine Protocol Enhancements,

PLANTATION, FL – April 30, 2025 – Representing Ibogaine by David Dardashti, Gavriel Dardashti will detail significant neuroscientific advancements enhancing ibogaine therapy protocols at the influential 2025 Psychedelic Conference in Denver, Colorado. Building on the foundational work of his father, founder David Dardashti, the presentation showcases how sophisticated technology refines and personalizes treatment, ...

Continue Reading →

Former Texas Governor And U.S. Senator Meet With State Lawmakers To Form National Ibogaine Access Plan

Drug policy reform advocates, public health experts and current and former government officials met for a summit in Colorado over the weekend to discuss how to move forward with state-led clinical research into ibogaine as a treatment for addiction, trauma and various neurodegenerative conditions.

Attendees at the three-day Aspen Ibogaine Meeting discussed science and policy around the plant-based psychedelic as well as how to go about building the necessary financial and legal infrastructure ...

Continue Reading →
Page 62 of 123 «...3040506061626364...»
UA-77446339-1